MaxCyte Management
Management criteria checks 2/4
MaxCyte's CEO is Maher Masoud, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is $890.37K, comprised of 50.5% salary and 49.5% bonuses, including company stock and options. directly owns 0.095% of the company’s shares, worth £270.99K. The average tenure of the management team and the board of directors is 1.5 years and 3.4 years respectively.
Key information
Maher Masoud
Chief executive officer
US$890.4k
Total compensation
| CEO salary percentage | 50.5% |
| CEO tenure | less than a year |
| CEO ownership | 0.09% |
| Management average tenure | 1.5yrs |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 09
Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%
May 30Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results
May 10Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term
Mar 14Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation
Mar 07Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%
Oct 07Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation
Aug 12MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%
May 15Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%
May 14We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth
Apr 27Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth
Nov 20Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation
Mar 02We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth
Nov 17We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn
Jul 25MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain
Feb 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$36m |
| Jun 30 2024 | n/a | n/a | -US$35m |
| Mar 31 2024 | n/a | n/a | -US$37m |
| Dec 31 2023 | US$890k | US$450k | -US$38m |
| Sep 30 2023 | n/a | n/a | -US$37m |
| Jun 30 2023 | n/a | n/a | -US$33m |
| Mar 31 2023 | n/a | n/a | -US$30m |
| Dec 31 2022 | US$791k | US$413k | -US$24m |
Compensation vs Market: Maher's total compensation ($USD890.37K) is about average for companies of similar size in the UK market ($USD988.12K).
Compensation vs Earnings: Maher's compensation has increased whilst the company is unprofitable.
CEO
Maher Masoud (49 yo)
less than a year
Tenure
US$890,365
Compensation
Mr. Maher Masoud is President, CEO & Executive Director of MaxCyte, Inc. since January 1, 2024 and served as its Head of Global Business Development and Legal Officer since November 2023 and had been its S...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$890.37k | 0.095% £ 271.0k | |
| Founder | 26.3yrs | US$3.14m | 0.32% £ 903.0k | |
| Chief Financial Officer | 1.7yrs | US$1.29m | no data | |
| Senior Vice President of Operations | less than a year | no data | no data | |
| Executive Vice President of Administration | 1.7yrs | US$948.33k | no data | |
| Senior Vice President | less than a year | no data | no data | |
| Executive Vice President of Global Sales | 10.2yrs | no data | 0.024% £ 67.7k | |
| Vice President of Corporate Development | 1.1yrs | no data | no data | |
| Senior Vice President of Human Resources | less than a year | no data | no data | |
| Consultant | 3.1yrs | US$264.50k | no data | |
| Senior VP of Technical Applications & Customer Support | 3.3yrs | no data | no data | |
| Chief Commercial Officer | 1.3yrs | no data | no data |
1.5yrs
Average Tenure
63yo
Average Age
Experienced Management: MXCT's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$890.37k | 0.095% £ 271.0k | |
| Independent Non-Executive Director | 20.7yrs | US$177.24k | 0.048% £ 136.3k | |
| Independent Non-Executive Director | 18.5yrs | US$170.49k | 0.36% £ 1.0m | |
| Independent Non-Executive Director | 2yrs | US$155.49k | 0% £ 0 | |
| Independent Non-Executive Chairman of the Board | 6.8yrs | US$190.49k | 0.095% £ 271.0k | |
| Independent Non-Executive Director | 19.7yrs | US$162.24k | 0.23% £ 671.4k | |
| Independent Non-Executive Director | 8.8yrs | US$160.49k | 0.11% £ 326.8k | |
| Independent Non-Executive Director | 3.4yrs | US$238.53k | 0% £ 0 | |
| Independent Non-Executive Director | 3.4yrs | US$243.03k | 0% £ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Member of Scientific Advisory Board | less than a year | US$897.25k | 0% £ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data |
3.4yrs
Average Tenure
65yo
Average Age
Experienced Board: MXCT's board of directors are considered experienced (3.4 years average tenure).